Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Shionogi & Ltd Un ADR (SGIOY)

Shionogi & Ltd Un ADR (SGIOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Shionogi & Ltd Un ADR 1-8 DOSHOMACHI 3-CHOME OSAKA M0 541-0045 JPN

www.shionogi.com P: 816-620-2216

Description:

Shionogi & Co., Ltd. engages in the research, development, manufacture and distribution of pharmaceuticals, diagnostic reagents, and medical devices. Its primary products Tivicay for HIV treatment; Mulpleta for the treatment of thrombocytopenia; Xofluza, an influenza drug; Symproic for opioid-induced constipation treatment and Fetroja, a multidrug-resistant for gram-negative bacterial infection treatment. Shionogi & Co., Ltd. is based in Osaka, Japan.

Key Statistics

Overview:

Market Capitalization, $K 13,043,429
Enterprise Value, $K 10,572,609
Shares Outstanding, K 1,186,176
Annual Sales, $ 3,002 M
Annual Net Income, $ 1,118 M
Last Quarter Sales, $ 662,080 K
Last Quarter Net Income, $ 234,540 K
EBIT, $ 346,280 K
EBITDA, $ 1,210 M
60-Month Beta 0.21
% of Institutional Shareholders 1.92%
Float, K 1,186,176
% Float 100.00%
Short Volume Ratio 0.11

Growth:

1-Year Return 5.13%
3-Year Return -16.63%
5-Year Return -20.43%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.21 on 05/13/24
Next Earnings Date 07/29/24 [--]
Earnings Per Share ttm 0.97
EPS Growth vs. Prev Qtr -4.55%
EPS Growth vs. Prev Year 16.67%
Annual Dividend Rate, $ 0.18
Annual Dividend Yield 1.60%
Most Recent Dividend 0.086 on 09/27/23
Next Ex-Dividends Date 03/26/24
Dividend Payout Ratio 9.40%
Most Recent Split 8-1 on 02/27/19

SGIOY Ratios

Ratio
Price/Earnings ttm 11.15
Price/Earnings forward 12.64
Price/Earnings to Growth 3.07
Return-on-Equity % 13.20%
Return-on-Assets % 11.63%
Profit Margin % 37.24%
Debt/Equity 0.00
Price/Sales 4.26
Price/Cash Flow 10.45
Price/Book 1.51
Book Value/Share 7.29
Interest Coverage 30.59

SGIOY Dividends

Date Value
09/27/23 $0.0860
09/29/22 $0.0780
09/27/21 $0.0880
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar